U.S. Department of Defense (DOD) Conceived in 2019, the Department of Defense (DOD), under its Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department (DTRA), developed a program called Discovery of MCMs (medical countermeasures) Against Novel Entities (DOMANE) “to rapidly identify a combination of drugs to impact the novel biological threat from multiple targets, which […]
